EXTON, Pa., Aug. 24 /PRNewswire/ — BioTrends Research Group,
Inc. recently published its TreatmentTrends®: Vascular
Access report. This report isbased on
online survey results from over 150 physicians (general
nephrologists, surgeons, interventional radiologists and
interventional nephrologists). It provides an in-depth view of the
dialysis vascular access market and current practice patterns
related to both vascular access placement and maintenance.
The report explores the roles of various physicians related to
vascular access, reasons for choice of different access options and
barriers to fistula use. It also looks at the type and frequency of
interventions being performed and impact on missed dialysis
sessions. The report also reviews controversies and challenges in
vascular access, physician perceptions and expectations about the
future of the dialysis vascular access market including the impact
of bundling and projected use of fistulas, grafts and catheters in
both incident and prevalent dialysis patients. Physician awareness,
perceptions and use of the latest access option, Hemosphere’s HeRO
device, is also included. Thought leaders, as well as companies /
representatives that are active in the vascular access field, are
identified.
“This unique report clearly demonstrates many of the challenges
that continue to exist regarding the improvement of incident and
prevalent arteriovenous fistula rates,” said Dr. Jay Wish, clinical
consultant at the Fistula First Breakthrough Initiative. “Moreover,
it reveals a disconnect among the expectations of nephrologists,
surgeons and interventionalists that may be a barrier to optimal
fistula use. It is hoped that continued research into some of these
areas of controversy will promote the development of more
evidence-based guidance regarding vascular access selection,
timing, monitoring, and the use of newer agents to increase short
and long-term patency.”
‘/>”/>
SOURCE